| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ORIGINAL ARTICLES |
From the Departments of Psychiatry (R.E.C., P.J.L., K.E.F., L.S.G., R.M.C.) and Medicine (R.E.C., J.B.McG), Washington University School of Medicine, and the Department of Veterans Affairs (P.J.L.), Medical Center, St. Louis, Missouri.
Address reprint requests to: Ray E. Clouse, MD, Professor of Medicine and Psychiatry, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8124, St. Louis, MO 63110. Email: rclouse{at}im.wustl.edu
OBJECTIVE: The protective effects of female gender on the appearance and course of coronary heart disease (CHD) in nondiabetic subjects are diminished in the presence of diabetes. Depression predicts onset of and poor outcome from CHD in nondiabetic populations. We hypothesized that the doubled rates of depression in female diabetic patients could help explain the high prevalence of CHD in women with diabetes.
METHOD: Seventy-six female type 1 and type 2 diabetic patients with (N=16) or without (N=60) active major depression (DSM-III) at index evaluation underwent systematic annual investigation of diabetes and its complications for up to 10 years. Occurrences of CHD and other macrovascular complications were examined in relation to depression status using survival analysis statistics. A multivariate model incorporating other CHD risk factors (age, duration of diabetes, body mass index, glycosylated hemoglobin, and presence of hypertension, hyperlipidemia, or tobacco use) was used to determine independent effects of depression on outcome.
RESULTS: Development of CHD was significantly more rapid in the depressed subset (p<0.01 between 10-year curves), an effect that persisted after controlling for base-line differences in body mass index. Depression also was retained as an independent predictor of CHD in the multivariate model with an age-adjusted hazard ratio of 5.2 (95% CI: 1.418.9; p=.01). In contrast, depression did not predict the development of clinically apparent peripheral or cerebrovascular disease.
CONCLUSIONS: In this sample of diabetic women, major depression was an independent risk factor that accelerated the development of CHD. Depression recognition and management may improve outcomes from diabetes in this gender subgroup.
Key Words: depression, coronary heart disease, diabetes, peripheral vascular disease, cerebrovascular disease.
Abbreviations: CHD = coronary heart disease;; DSM-III = Diagnostic and Statistical Manual of Mental Disorders, Version 3;; DIS = Diagnostic Interview Schedule, Version 3.
This article has been cited by other articles:
![]() |
M. M. Weissman, Y. Neria, M. J. Gameroff, D. J. Pilowsky, P. Wickramaratne, R. Lantigua, S. Shea, and M. Olfson Positive Screens for Psychiatric Disorders in Primary Care: A Long-Term Follow-Up of Patients Who Were Not in Treatment Psychiatr Serv, February 1, 2010; 61(2): 151 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Peters and K. Mengersen Selective Reporting of Adjusted Estimates in Observational Epidemiology Studies: Reasons and Implications for Meta-analyses Eval Health Prof, December 1, 2008; 31(4): 370 - 389. [Abstract] [PDF] |
||||
![]() |
W. A. Rush, R. R. Whitebird, M. R. Rush, L. I. Solberg, and P. J. O'Connor Depression in Patients with Diabetes: Does It Impact Clinical Goals? J Am Board Fam Med, September 1, 2008; 21(5): 392 - 397. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. M. Sanders, C. W. Wilkinson, G. J. Taborsky Jr., S. Al-Noori, W. Daumen, A. Zavosh, and D. P. Figlewicz The selective serotonin reuptake inhibitor sertraline enhances counterregulatory responses to hypoglycemia Am J Physiol Endocrinol Metab, May 1, 2008; 294(5): E853 - E860. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, J. J Guo, H. Li, L. Wulsin, and N. C Patel Risk of Cerebrovascular Events Associated with Antidepressant Use in Patients with Depression: A Population-Based, Nested Case-Control Study Ann. Pharmacother., February 1, 2008; 42(2): 177 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Penckofer, C. E. Ferrans, B. Velsor-Friedrich, and S. Savoy The Psychological Impact of Living With Diabetes: Women's Day-to-Day Experiences The Diabetes Educator, July 1, 2007; 33(4): 680 - 690. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Williams, R. E. Clouse, B. D. Nix, E. H. Rubin, G. S. Sayuk, J. B. McGill, A. J. Gelenberg, P. S. Ciechanowski, I. B. Hirsch, and P. J. Lustman Efficacy of Sertraline in Prevention of Depression Recurrence in Older Versus Younger Adults With Diabetes Diabetes Care, April 1, 2007; 30(4): 801 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Trief Depression in Elderly Diabetes Patients Diabetes Spectr, April 1, 2007; 20(2): 71 - 75. [Full Text] [PDF] |
||||
![]() |
P. J. Lustman, M. M. Williams, G. S. Sayuk, B. D. Nix, and R. E. Clouse Factors Influencing Glycemic Control in Type 2 Diabetes During Acute- and Maintenance-Phase Treatment of Major Depressive Disorder With Bupropion Diabetes Care, March 1, 2007; 30(3): 459 - 466. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Anderson, C. Horton, M. L. O'Toole, C. A. Brownson, P. Fazzone, and E. B. Fisher Integrating Depression Care With Diabetes Care in Real-World Settings: Lessons From the Robert Wood Johnson Foundation Diabetes Initiative Diabetes Spectr, January 1, 2007; 20(1): 10 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Nicholson, H. Kuper, and H. Hemingway Depression as an aetiologic and prognostic factor in coronary heart disease: a meta-analysis of 6362 events among 146 538 participants in 54 observational studies Eur. Heart J., December 1, 2006; 27(23): 2763 - 2774. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Elwing, P. J. Lustman, H. L. Wang, and R. E. Clouse Depression, Anxiety, and Nonalcoholic Steatohepatitis Psychosom Med, July 1, 2006; 68(4): 563 - 569. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Lustman, R. E. Clouse, B. D. Nix, K. E. Freedland, E. H. Rubin, J. B. McGill, M. M. Williams, A. J. Gelenberg, P. S. Ciechanowski, and I. B. Hirsch Sertraline for Prevention of Depression Recurrence in Diabetes Mellitus: A Randomized, Double-blind, Placebo-Controlled Trial. Arch Gen Psychiatry, May 1, 2006; 63(5): 521 - 529. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Williams, R. E. Clouse, and P. J. Lustman Treating Depression to Prevent Diabetes and Its Complications: Understanding Depression as a Medical Risk Factor Clin. Diabetes, April 1, 2006; 24(2): 79 - 86. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Trief, P. C. Morin, R. Izquierdo, J. A. Teresi, J. P. Eimicke, R. Goland, J. Starren, S. Shea, and R. S. Weinstock Depression and Glycemic Control in Elderly Ethnically Diverse Patients With Diabetes: The IDEATel Project Diabetes Care, April 1, 2006; 29(4): 830 - 835. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Miller, N. Rohleder, C. Stetler, and C. Kirschbaum Clinical Depression and Regulation of the Inflammatory Response During Acute Stress Psychosom Med, September 1, 2005; 67(5): 679 - 687. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Z. Naqvi, S. S.A. Naqvi, and C. N. B. Merz Gender Differences in the Link Between Depression and Cardiovascular Disease Psychosom Med, May 1, 2005; 67(Supplement_1): S15 - S18. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Bell, S. L. Smith, T. A. Arcury, B. M. Snively, J. M. Stafford, and S. A. Quandt Prevalence and Correlates of Depressive Symptoms Among Rural Older African Americans, Native Americans, and Whites With Diabetes Diabetes Care, April 1, 2005; 28(4): 823 - 829. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Lustman, R. E. Clouse, P. S. Ciechanowski, I. B. Hirsch, and K. E. Freedland Depression-Related Hyperglycemia in Type 1 Diabetes: A Mediational Approach Psychosom Med, March 1, 2005; 67(2): 195 - 199. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Lustman and R. E. Clouse Section III: Practical Considerations in the Management of Depression in Diabetes Diabetes Spectr, July 1, 2004; 17(3): 160 - 166. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |